Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ovid Therapeutics (OVID) Tax Provisions (2021 - 2022)

Ovid Therapeutics filings provide 2 years of Tax Provisions readings, the most recent being $50000.0 for Q1 2022.

  • Quarterly Tax Provisions fell 90.01% to $50000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $50000.0 through Dec 2022, down 96.24% year-over-year, with the annual reading at $1.3 million for FY2021, N/A changed from the prior year.
  • Tax Provisions hit $50000.0 in Q1 2022 for Ovid Therapeutics, up from -$349714.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.5 million in Q2 2021 and bottomed at -$349714.0 in Q4 2021.